Switch to: References

Add citations

You must login to add citations.
  1. Hope and Exploitation in Commercial Provision of Assisted Reproductive Technologies.Anthony Wrigley, Gabriel Watts, Wendy Lipworth & Ainsley J. Newson - 2023 - Hastings Center Report 53 (5):30-41.
    Innovation is a key driver of care provision in assisted reproductive technologies (ART). ART providers offer a range of add‐on interventions, aiming to augment standard in vitro fertilization protocols and improve the chances of a live birth. Particularly in the context of commercial provision, an ever‐increasing array of add‐ons are marketed to ART patients, even when evidence to support them is equivocal. A defining feature of ART is hope—hope that a cycle will lead to a baby or that another test (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Polygenic risk scoring of human embryos: a qualitative study of media coverage.Olga Tšuiko, Pascal Borry, Maria Siermann & Tiny Pagnaer - 2021 - BMC Medical Ethics 22 (1):1-8.
    BackgroundCurrent preimplantation genetic testing (PGT) technologies enable embryo genotyping across the whole genome. This has led to the development of polygenic risk scoring of human embryos (PGT-P). Recent implementation of PGT-P, including screening for intelligence, has been extensively covered by media reports, raising major controversy. Considering the increasing demand for assisted reproduction, we evaluated how information about PGT-P is communicated in press media and explored the diversity of ethical themes present in the public debate.MethodsLexisNexis Academic database and Google News were (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations